April 12, 2011 – TechniScan's breast ultrasound technology and clinical results will be featured at the American Institute of Ultrasound Medicine's annual conference in New York this week. The highlights will include the latest results from an ongoing clinical study using the company’s Warm Bath Ultrasound (WBU) technology. As part of an educational session on advanced breast ultrasound imaging, Michael Andre, Ph.D., director of the study at the University of California, San Diego Moores Cancer Center will lead the discussion and explaining the latest results. The WBU system employs the properties of reflection ultrasound and maps the breast by sending transmission ultrasound waves through it, which significantly improves the clinical information. It may also allow a radiologist to determine whether a breast lesion is a cyst, a benign fibroademona or a malignancy – all without a biopsy. Two of the world's leading experts on transmission ultrasound and the mathematics of inverse scattering, James Wiskin, Ph.D., a TechniScan founder and adjunct professor at the University of Utah Department of Bioengineering, along with his colleague David Borup, Ph.D., are co-authors on the study. Wiskin will also be participating in the New York session. "This conference is a great opportunity for other physicians and scientists to learn of the scientific and medical advances the TechniScan system demonstrates," said Andre. The goal of the new technology is to improve breast imaging using a quick and practical approach for examining the entire breast in detail and looking inside the breast for abnormalities. The images are captured using a comfortable, radiation-free method as a woman lies prone on an examination table and ultrasound is directed, using warm water as a coupling medium, into the woman's breast tissue. The UC San Diego Moores Cancer Center has scanned more than 150 women in the two years of the study and will be sharing detailed comparisons of the WBU technology to sonography and MRI during the education session. For more information: www.tsni.com
If you enjoy this content, please share it with a colleague
Related Content
May 1, 2024 — Hologic, Inc., a global leader in women’s health, today announced that it signed a definitive agreement to ...
May 1, 2024 — The American College of Radiology (ACR) has issued a statement on the newly released Final USPSTF Breast ...
April 30, 2024 — The U.S. Preventive Services Task Force (Task Force) today published a final recommendation statement ...
From implementing artificial intelligence effectively, advocating for radiologists, and working tirelessly to expand ...
Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...
April 2, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced ...
March 20, 2024 — Interval breast cancer is one that appears between two reviews of a screening program. That is, it is ...
March 15, 2024 — Screening-detected radial scars without atypia at core-needle biopsy (CNB) have a low upstaging rate to ...
March 6, 2024 — There is a pressing need to explore and understand which social determinants of health (SDOH) and health ...
February 20, 2024 — Annual breast cancer screening beginning at age 40 and continuing to at least age 79 results in the ...